Jpmorgan Chase & CO Medifast Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Medifast Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 57,455 shares of MED stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,455
Previous 22,438
156.06%
Holding current value
$1.1 Million
Previous $489,000
124.74%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MED
# of Institutions
175Shares Held
10.3MCall Options Held
554KPut Options Held
545K-
Jim Simons Renaissance Technologies LLC | New York, Ny959KShares$18.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY829KShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA723KShares$13.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny469KShares$8.99 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT390KShares$7.47 Million0.01% of portfolio
About MEDIFAST INC
- Ticker MED
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Personal Services
- Shares Outstandng 11,017,900
- Market Cap $211M
- Description
- Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...